Wockhardt receives US nod for cardiac drug
Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.
Read more on rediff.com
AMRI Announces Phase I Study Of Novel Drug For Obesity Treatment
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity.
Read more on PharmaceuticalOnline
Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard.
Read more on News-Medical-Net